Quick Answer
NIKA PHARMACEUTICALS, INC reported Diluted EPS of $0.00 per share for fiscal year 2025.
NIKA PHARMACEUTICALS, INC Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $0.00 | — |
| 2024 | $0.00 | — |
| 2023 | $0.00 | — |
| 2022 | $0.00 | — |
| 2021 | $0.00 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.00 | — | — |
| June 30, 2025 | $0.00 | — | — |
| March 31, 2025 | $0.00 | — | — |
| September 30, 2024 | $0.00 | — | — |
| June 30, 2024 | $0.00 | — | — |
| March 31, 2024 | $0.00 | — | — |
| June 30, 2023 | $0.00 | — | — |
| March 31, 2023 | $0.00 | — | — |
- The most recent figure is from NIKA PHARMACEUTICALS, INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: